🇺🇸 FDA

Company profile · Sponsor

Solid

Solid Biosciences

SLDB · NYSE biotech CHARLESTOWN, MA, USA
Pipeline
16
Drugs
4
Patents
2

Quick answer

Solid (SLDB) is a biotech company. headquartered in CHARLESTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 16 pipeline programs, 4 drugs, and 2 patents to this profile..

Company facts

Ticker SLDB
Exchange NYSE
Company type biotech
Headquarters CHARLESTOWN, MA, USA
SEC CIK 0001707502

Pipeline (16)

Search pipeline →

  1. IP

    Solid

    Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  2. SGT-003

    Solid

    Duchenne Muscular Dystrophy

    phase 3 gene therapy active

    2 trials

  3. dactinomycin

    Solid

    Sarcoma

    phase 3 mab active

    1 trial

  4. filgrastim

    Solid

    Lung Cancer

    phase 3 mab active

    1 trial

  5. filgrastim

    Solid

    Ovarian Cancer

    phase 3 mab completed

    1 trial

  6. filgrastim

    Solid

    Lymphoma

    phase 3 mab active

    2 trials

  7. trofosfamide, idarubicin, etoposide

    Solid

    Soft Tissue Sarcoma

    phase 3 small molecule completed

    1 trial

  8. A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males with Duchenne Muscular Dystrophy

    Solid

    Duchenne muscular dystrophy

    phase 2 other active

    1 trial

  9. Bevacizumab/Irinotecan

    Solid

    Glioblastoma

    phase 2 small molecule completed

    1 trial

  10. Cetuximab

    Solid

    Head and Neck Neoplasm

    phase 2 small molecule completed

    1 trial

  11. Erlotinib

    Solid

    Leptomeningeal Carcinomatosis

    phase 2 small molecule terminated

    1 trial

  12. SGT-001

    Solid

    Duchenne Muscular Dystrophy

    phase 2 gene therapy active

    1 trial

  13. docetaxel+CDDP

    Solid

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  14. genexolPM + cisplatin

    Solid

    Locally Advanced Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  15. SGT-212

    Solid

    Friedreich's Ataxia (FA)

    phase 1 small molecule active

    1 trial

  16. SGT-501

    Solid

    Catecholaminergic Polymorphic Ventricular Tachycardia

    phase 1 small molecule active

    1 trial

Drugs (4)

Search drugs →

  1. aminosalicylate sodium

    P.A.S. SODIUM

    ORAL approved

  2. ampicillin sodium

    AMPICILLIN SODIUM

    INJECTION approved

  3. penicillin g potassium

    PENTIDS '800'

    INJECTION approved

  4. penicillin g procaine

    PENICILLIN G PROCAINE

    INJECTION approved

Patents (2)

Search patents →

  1. US 11172694

    Core-shell structure with titanium dioxide core

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7585852

    Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Solid?

Solid (SLDB) is a biotech company. headquartered in CHARLESTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 16 pipeline programs, 4 drugs, and 2 patents to this profile..

What pipeline programs does Solid sponsor?

We track 16 ClinicalTrials.gov-linked programs for Solid, including IP and 15 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Solid company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.